GenSight Biologics S.A. (GSGTF)
USD 0.32
(0.0%)
USD 0.32
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -24.66 Million | -38.12 Million | -20.42 Million | -19.27 Million | -31.55 Million | -32.44 Million |
| Net Income | -26.22 Million | -29.56 Million | -32.52 Million | -41.61 Million | -34.64 Million | -38.24 Million |
| Depreciation & Amortization | 2.17 Million | 1.1 Million | 1.05 Million | 1.13 Million | 1.1 Million | 360.09 Thousand |
| Deferred income taxes | 26 Thousand | -341.2 Thousand | -5.01 Million | -4.33 Million | -4.71 Million | - |
| Stock-based compensation | 587 Thousand | -3.36 Million | 4.83 Million | 3.45 Million | 1.3 Million | 2.42 Million |
| Change in working capital | 2.45 Million | -4.19 Million | 5.5 Million | 6.81 Million | -162.76 Thousand | 2.16 Million |
| Other non-cash items | -3.68 Million | -1.76 Million | 5.71 Million | 15.27 Million | 5.55 Million | 1.97 Million |
| Investing Cash Flow | 209 Thousand | 184.08 Thousand | -18.18 Thousand | -460.05 Thousand | -114.49 Thousand | -757.9 Thousand |
| Investments in PPE | -10 Thousand | -269.7 Thousand | -36.37 Thousand | -7341.30 | -85.3 Thousand | -904.23 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | -452.71 Thousand | -29.18 Thousand | - |
| Sales/Maturities of investments | 241.71 Thousand | 453.78 Thousand | 18.18 Thousand | - | - | 146.32 Thousand |
| Other Investing Activities | -22.71 Thousand | 1.00 | 18.21 Thousand | 0.30 | -1.00 | 144.34 Thousand |
| Financing Cash Flow | 15.85 Million | 2.09 Million | 27.93 Million | 42.29 Million | 23.84 Million | -131.46 Thousand |
| Debt repayment | -1.08 Million | -3.18 Million | -3.48 Million | -14.32 Million | -6.36 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -99 Thousand | -206.55 Thousand | -305 Thousand | - | - | -140.6 Thousand |
| Common Stock Issuance | 4.01 Million | 40.66 Thousand | 32.08 Million | 28.83 Million | 18.2 Million | 9145.20 |
| Other Financing Activities | 4.02 Million | 11.82 Million | -1136.64 | 27.78 Million | 12 Million | 9165.00 |
| Accounts receivables | -1103.74 | 809.1 Thousand | -793.37 Thousand | 967.82 Thousand | -947.38 Thousand | -3.96 Million |
| Accounts payables | -2.46 Million | -2.3 Million | 2.72 Million | 420.9 Thousand | -250.31 Thousand | 5.98 Million |
| Inventory | -254.57 Thousand | - | - | 1.00 | - | - |
| Other working capital | 5.17 Million | -2.69 Million | 3.57 Million | 5.42 Million | 1.03 Million | 150.89 Thousand |
| Cash at beginning of period | 10.61 Million | 50.33 Million | 46.42 Million | 21.6 Million | 29.99 Million | 66.58 Million |
| Cash at end of period | 2.13 Million | 11.35 Million | 50.33 Million | 46.42 Million | 21.6 Million | 29.99 Million |
| Capital Expenditure | -10 Thousand | -269.7 Thousand | -36.37 Thousand | -7341.30 | -85.3 Thousand | -904.23 Thousand |
| Effect of forex changes on cash | 119 Thousand | -193 Thousand | -238 Thousand | 254 Thousand | -22 Thousand | -47 Thousand |
| Net cash flow / Change in cash | -8.47 Million | -38.98 Million | 3.91 Million | 24.81 Million | -8.38 Million | -36.58 Million |
| Free Cash Flow | -24.67 Million | -38.39 Million | -20.46 Million | -19.28 Million | -31.64 Million | -33.35 Million |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q2 | 2021 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -6.26 Million | -26.22 Million | -13.04 Million | -29.56 Million | -11.22 Million | -32.52 Million |
| Depreciation & Amortization | 765.85 Thousand | 2.17 Million | 539.91 Thousand | 1.1 Million | 507.23 Thousand | 1.05 Million |
| Deferred income taxes | - | 26 Thousand | - | -341.2 Thousand | - | -5.01 Million |
| Stock-based compensation | - | 587 Thousand | - | -3.36 Million | - | 4.83 Million |
| Change in working capital | -831.18 Thousand | 2.45 Million | 483.19 Thousand | -4.19 Million | -4.06 Million | 5.5 Million |
| Other non-cash items | -1.6 Million | -3.68 Million | -7.56 Million | -1.76 Million | 4.1 Million | 5.71 Million |
| Investing Cash Flow | 12.85 Thousand | 209 Thousand | 166.88 Thousand | 184.08 Thousand | 97.46 Thousand | -18.18 Thousand |
| Investments in PPE | -1071.12 | -10 Thousand | - | -269.7 Thousand | -156.15 Thousand | -36.37 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 13.92 Thousand | 241.71 Thousand | 166.88 Thousand | 453.78 Thousand | 253.61 Thousand | 18.18 Thousand |
| Other Investing Activities | - | -22.71 Thousand | - | 1.00 | - | 18.21 Thousand |
| Financing Cash Flow | 13.06 Million | 15.85 Million | 7.28 Million | 2.09 Million | -3.03 Million | 27.93 Million |
| Debt repayment | - | -1.08 Million | -7.72 Million | -3.18 Million | -2.38 Million | -3.48 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -23.56 Thousand | -99 Thousand | - | -206.55 Thousand | -253.61 Thousand | -305 Thousand |
| Common Stock Issuance | 13.51 Million | 4.01 Million | 57.8 Thousand | 40.66 Thousand | 32.48 Thousand | 32.08 Million |
| Other Financing Activities | -434.87 Thousand | 4.02 Million | -494.1 Thousand | 11.82 Million | - | -1136.64 |
| Accounts receivables | 1.52 Million | -1103.74 | 378.48 Thousand | 809.1 Thousand | -3.6 Million | -793.37 Thousand |
| Accounts payables | -924.37 Thousand | -2.46 Million | 2.31 Million | -2.3 Million | -2.57 Million | 2.72 Million |
| Inventory | - | -254.57 Thousand | - | - | - | - |
| Other working capital | -1.43 Million | 5.17 Million | -2.21 Million | -2.69 Million | 2.1 Million | 3.57 Million |
| Cash at beginning of period | 2.31 Million | 10.61 Million | 25.3 Million | 50.33 Million | 64.35 Million | 46.42 Million |
| Cash at end of period | 7.43 Million | 2.13 Million | 1.11 Million | 11.35 Million | 25.3 Million | 50.33 Million |
| Capital Expenditure | -1071.12 | -10 Thousand | - | -269.7 Thousand | -156.15 Thousand | -36.37 Thousand |
| Effect of forex changes on cash | - | 119 Thousand | 0.22 | -193 Thousand | -18.23 Million | -238 Thousand |
| Net cash flow / Change in cash | 5.11 Million | -8.47 Million | -24.19 Million | -38.98 Million | -39.04 Million | 3.91 Million |
| Free Cash Flow | -7.93 Million | -24.67 Million | -17.97 Million | -38.39 Million | -18.02 Million | -20.46 Million |
PRSMJOHNSN
ENBETRD
BLAL
WNDR
CICN
V03